Overview
- Adams reported rapid decline from metastasized prostate cancer and said he was heading to the emergency room after posting his plea.
- He said Kaiser Permanente–Northern California approved Pluvicto but failed to schedule the brief IV infusion needed to deliver it.
- Trump amplified the request on Truth Social with “on it,” following outreach from HHS Secretary Robert F. Kennedy Jr. asking how to reach Adams.
- White House allies, including Dan Scavino and Donald Trump Jr., signaled they were elevating the case, with Scavino noting Dr. Mehmet Oz and HHS were tracking it.
- A Kaiser‑affiliated physician said medical directors were alerted to the urgency and would contact Adams today; Pluvicto is an FDA‑approved radioligand therapy for PSMA‑positive metastatic prostate cancer.